Aldeyra Therapeutics

Aldeyra shows FDA-rejected reproxalap improves eye discomfort in new phase 3 study
Fierce Biotech
Thu, 08/8/24 - 10:25 pm
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
FDA Rejects Aldeyra’s Dry Eye Drug, Cites Need for Additional Trial
BioSpace
Wed, 11/29/23 - 12:03 pm
Aldeyra Therapeutics
reproxalap
FDA
dry eye disease
Aldeyra Anticipates FDA Rejection of Dry Eye Drug Following Regulatory Meeting
BioSpace
Tue, 10/17/23 - 10:17 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Aldeyra's roller coaster month ends with 'positive' phase 2 chronic cough readout
Fierce Biotech
Tue, 06/27/23 - 11:33 am
Aldeyra Therapeutics
clinical trials
ADX‑629
chronic cough
Aldeyra Therapeutics reports that FDA rejects eye cancer drug
Benzinga
Wed, 06/21/23 - 10:56 pm
Aldeyra Therapeutics
FDA
eye cancer
ADX-2191
Go or no go? Key FDA decisions for Argenx and Regeneron
EP Vantage
Wed, 05/31/23 - 10:51 am
FDA
Albireo Pharma
Aldeyra Therapeutics
Alvotech
Amneal Pharmaceuticals
Argenx
ARS Pharmaceuticals
AstraZeneca
Bayer
Bio-Thera Solutions
Biogen
BioMarin Pharmaceutical
Bristol Myers Squibb
Eisai
Eton Pharmaceuticals
F2G
Fabre-Kramer Pharmaceuticals
Fresenius
GSK
Intercept Pharmaceuticals
Ipsen
Ironwood Pharmaceuticals
Merck
Novaliq
Pfizer
Regeneron
Roche
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Takeda
Teva Pharmaceutica
UCB Pharma
Major readouts on the horizon for small developers
EP Vantage
Fri, 03/31/23 - 10:19 am
Aldeyra Therapeutics
Autolus Therapeutics
Bavarian Nordic
BioXcel Therapeutics
Disc Medicine
Editas Medicine
Immunogen
Lantheus
Mersana Therapeutics
NGM Biopharmaceuticals
Omeros
Roche
Sutro BioPharma
uniQure
Valneva
Viking Therapeutics
Aldeyra reports positive data from dry eye disease therapy trial
Clinical Trials Arena
Wed, 03/1/23 - 10:08 am
Aldeyra Therapeutics
clinical trials
reproxalap
dry eye disease
Aldeyra’s sights set on November PDUFA
Endpoints
Tue, 02/7/23 - 11:57 am
Aldeyra Therapeutics
dry eye disease
reproxalap
FDA
Aldeyra says eye drop clears three dry eye signals en route to FDA
Endpoints
Tue, 07/12/22 - 10:51 am
Aldeyra Therapeutics
dry eye disease
FDA
clinical trials
reproxalap
Aldeyra Prepares to Submit Dry Eye Disease Treatment Reproxalap to FDA
BioSpace
Thu, 06/9/22 - 10:22 am
Aldeyra Therapeutics
dry eye disease
reproxalap
clinical trials
Aldeyra builds case for troubled dry eye drug reproxalap
Pharmaforum
Wed, 01/12/22 - 10:52 am
Aldeyra Therapeutics
dry eye disease
reproxalap
Watch out Claritin: Aldeyra announces clean sweep in PhIII for new allergy drug
Endpoints
Tue, 04/27/21 - 11:21 pm
Aldeyra Therapeutics
clinical trials
allergies
reproxalap
ragweed pollen allergy
3 Biotech Stocks That Jumped Last Week
Motley Fool
Sun, 01/17/21 - 04:54 pm
biotech
biotech stocks
Lexicon Pharmaceuticals
sotagliflozin
Nucana
Aldeyra Therapeutics
reproxalap
The Week Ahead In Biotech: FDA Decisions, Johnson & Johnson Among Big Pharma Earnings
Yahoo/Benzinga
Mon, 10/14/19 - 09:43 am
JNJ
Flexion Therapeutics
Novartis
Amgen
Clearside Biomedical
Alexion
Assertio Therapeutics
Aldeyra Therapeutics
Lineage Therapeutics
IMMUTEP
Marinus Pharma
Aldeyra's Reproxalap Falls Short in Anterior Uveitis Trial
BioSpace
Wed, 06/26/19 - 10:39 am
Aldeyra Therapeutics
reproxalap
non-infectious anterior uveitis
The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs
Yahoo/Benzinga
Sun, 04/28/19 - 10:00 pm
Regeneron
Sanofi
Praluent
FDA
Heron Therapeutics
HTX-011
Nabiva
Orchard Therapeutics
Akari Therapeutics
Aldeyra Therapeutics
BioTime
Audentes Therapeutics
Adaptimmune
GW Pharma
Ionis
Biogen
Ovid Therapeutics
TransMedics
IPOs
Trevi Therapeutics
New Data Puts Aldeyra One Step Closer to FDA Filing for Eye Drug
Xconomy
Tue, 03/26/19 - 09:45 am
Aldeyra Therapeutics
clinical trials
FDA
eye health
reproxalap
seasonal allergic conjunctivitis
Aldeyra plans reproxalap phase 3 after wrapping up dry eye disease trial
Fierce Biotech
Wed, 09/26/18 - 10:02 am
Aldeyra Therapeutics
dry eye disease
clinical trials
reproxalap
J&J collaborates with Aldeyra on new drugs for systemic inflammatory diseases
Endpoints
Tue, 02/27/18 - 09:49 am
JNJ
Aldeyra Therapeutics
inflammatory disease
R&D

Pages